What Neomycin Sulphate Is
Neomycin sulphate is an aminoglycoside antibiotic produced by fermentation and supplied as a water-soluble sulphate salt for veterinary use. It is active against many Gram-negative bacteria, including Escherichia coli and Salmonella species, and against some Gram-positive organisms. Because it is poorly absorbed from the gastrointestinal tract after oral administration, it acts mainly inside the gut, which is why it is used for local rather than systemic therapy. Commercial material is a mixture of neomycin B and neomycin C, and its strength is expressed in international units per milligram rather than by weight alone.
Specifications and Quality Parameters
| Parameter | Typical specification |
|---|---|
| Product name | Neomycin sulphate, veterinary grade |
| Appearance | White to yellowish, free-flowing powder |
| Potency | Not less than 650 IU per mg on the dried basis |
| Solubility | Freely soluble in water, practically insoluble in ethanol |
| pH of aqueous solution | About 5.0 to 7.5 |
| Loss on drying | Within the limit of the applicable monograph |
| Heavy metals | Within the limit of the applicable monograph |
| Standard packing | 25 kg fibre drum with inner liner |
| Storage | Airtight, protected from light, at controlled room temperature |
Potency is the primary commercial parameter, and buyers normally purchase on a labelled unit content rather than on gross weight, because the fermentation route gives a mixture whose B and C component ratio affects the assay. Assay methods, sulphate content and microbial limits should be stated in the purchase specification.
Gastrointestinal Indications in Livestock and Poultry
Neomycin sulphate is used to treat and control bacterial enteritis and diarrhoea in cattle, sheep, goats, swine and poultry. In calves and lambs it is also applied against bacterial enteritis and mange, and in chickens and turkeys it is used for Escherichia coli infections of the digestive tract. Water-soluble powder presentations are administered through drinking water, while premix and feed-grade presentations support group medication where local regulations allow. In dogs and cats the substance is occasionally used for hepatic encephalopathy as a veterinary-directed off-label application.
Species Limits and Adverse Effects
The product must not be given to horses, hamsters or rabbits, in which oral aminoglycosides can disturb the gut flora and cause severe, potentially fatal diarrhoea. In other species, gastrointestinal reactions such as vomiting, diarrhoea, reduced feed intake and lethargy may occur. Because aminoglycosides are potentially ototoxic and nephrotoxic, prolonged or high-level exposure has been associated with hearing loss, head tilt, and increased thirst and urination. Veterinary supervision, correct dosing and observance of the withdrawal period required in the destination market are essential for safe use.
Dosage Forms, Packaging and Sourcing
Water-soluble powder for administration through drinking water
Oral solution concentrates for farm-level dilution
Feed premix and granulated blends for group medication
Bulk packing in 25 kg fibre drums with a food-grade inner liner
Smaller foil bags of 1 kg and 5 kg for compounding and repackaging
Bulk material is a fine, hygroscopic powder, so it is packed with a moisture barrier liner and stored airtight away from moisture, heat and direct sunlight in a dry, ventilated warehouse. Segregation from other feed additives reduces the risk of cross-contamination during storage and blending. Shelf life, retest interval and potency retention are normally agreed between producer and buyer and supported by stability data.
Veterinary pharmaceutical manufacturers and feed-additive blenders should also review the potency assay method, the sulphate profile, particle size distribution for blending uniformity, and the documentation package needed for product registration in the destination market. Batch-to-batch potency consistency matters more than the headline figure, because every formulation is calculated on the labelled unit content. A stability protocol covering accelerated and long-term conditions supports the shelf-life claim printed on the finished product.
Frequently Asked Questions
Q: What is neomycin sulphate used for in animals?
It is used to treat and control bacterial infections of the intestinal tract in cattle, sheep, goats, swine and poultry, including enteritis and diarrhoea caused by susceptible organisms.
Q: Which animals must not receive neomycin?
It should not be given to horses, hamsters or rabbits, because oral aminoglycosides can cause severe and potentially fatal diarrhoea in these species.
Q: How is the strength of neomycin sulphate expressed?
Strength is expressed in international units per milligram; veterinary grades are commonly specified at not less than 650 IU per mg on the dried basis.
Q: What side effects can occur?
Gastrointestinal effects such as vomiting, diarrhoea, loss of appetite and lethargy can occur, and prolonged use carries a risk of ear and kidney toxicity.
Q: How is neomycin sulphate supplied in bulk?
It is normally supplied as a water-soluble powder in 25 kg fibre drums with an inner liner, or in 1 kg and 5 kg foil bags for repackers.
Q: How should neomycin sulphate be stored?
Keep containers airtight, protected from light and moisture, at controlled room temperature, and separate the material from other feed additives to avoid cross-contamination.